China's Xiaomi loses a top exec

Hugo Barra, a VP at the Chinese mobile device maker, announced on Sunday he'll be leaving the company next month and moving back to Silicon Valley after 3.5 years. Hiring him away from Google was considered a big get for Xioami at the time.

Why now? Barra says in a Facebook post that his lifestyle at Xiaomi has started to take a toll on him and his health. At the same time, he says Xiaomi has grown enough that it can continue to thrive without him. After some time off, he'll be "embarking on a new adventure back in Silicon Valley."

What about Xiaomi? Barra's departure undoubtedly raises questions about Xiaomi's health.

  • Earlier this month, the company declined for the first time to release sale numbers, with CEO Lei Jung admitting the company grew too fast.
  • Xiaomi's meteoric rise made it one of the most valuable private companies in the world, but whether it can continue to justify remains to be seen.
  • The company has yet to make a meaningful dent in the U.S. market.
Samsung's Note 7 investigation

Samsung officially concludes that the faulty and exploding batteries in its Note 7 smartphones were due to flaws in the design and manufacturing of the batteries

The details: Specifically, Samsung blames a design flaw in the batteries from one its manufacturers, which caused short circuits. Its other manufacturer—which supplied the replacement batteries—had a welding defect that could lead to fires.

Next steps: Nevertheless, Samsung takes full responsibility and has devised a new 8-point testing plan for all lithium ion batteries in its devices.

Go deeper

Big Pharma launches $1B venture to incentivize new antibiotics

Illustration: Lazaro Gamio/Axios

A group of large drug companies launched a $1 billion AMR Action Fund Thursday in collaboration with policymakers, philanthropists and development banks to push the development of two to four new antibiotics by 2030.

Why it matters: Antimicrobial resistance (AMR) is a growing problem — possibly killing up to 20 million people annually by 2050 — but a severe lack of R&D market incentives has hampered efforts to develop a robust antibiotic pipeline to address the issue.

Updated 25 mins ago - Politics & Policy

Inside Geoffrey Berman's closed-door testimony

Berman arrives on Capitol Hill Thursday. Photo: Saul Loeb/AFP via Getty Images

Geoffrey Berman, the former top federal prosecutor in Manhattan, was expected to say in closed-door testimony today that Attorney General Bill Barr repeatedly urged him to take another job, warned him that getting fired would not be good for his resume or job prospects and steered him toward a high-level Justice Department post in DC.

Driving the news: Axios has obtained a copy of Berman's opening statement for his closed-door hearing before the House Judiciary Committee.

34 mins ago - Health

Schools confront broadband access crisis

Illustration: Sarah Grillo/Axios

School districts are taking it upon themselves to help families get connected to the internet as they face down a long future of virtual learning.

Why it matters: In the COVID-19 era of education, broadband is an essential service that families need to stay connected — and that school systems require to equitably educate children in their districts.